Capitan Orthopedics

Capitan Orthopedics is a medical device company developing the SupraSpacer implant and procedure to treat irreparable rotator cuff tears in younger, active patients. The implant has received FDA Breakthrough Device Designation and the company is preparing its first in-human clinical trial.

  • Seed
  • Clinical Trials
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Aug 18, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Aug 18, 2026

    $4.1M

    Seed

    Led by Genesis Innovation Group

    • Genesis Innovation Group

    Article coming soon.

Pricing

Research Capitan Orthopedics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Capitan Orthopedics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational